convert semaglutide to tirzepatide Switching between weight-loss medications Semaglutide & Tirzepatide Dosing Guide:

Large-scale trials demonstrate that semaglutide may modestly reduce systolic blood pressure by approximately 25 mmHg, likely due to weight loss and improved metabolic health

Another study stressed the need for careful patient selection and monitoring when using semaglutide in patients without a gallbladder

They are now widely used for weight loss

prescribing information includes a caution to monitor patients with diabetic retinopathy for progression

Major trials including STEP 1-4 (semaglutide) and SURMOUNT 1-4 (tirzepatide) demonstrate 15-22% average weight loss over 68 weeks with improved cardiovascular markers and glucose control

When fatigue persists, professional guidance becomes crucial